Results 51 to 60 of about 339 (90)

Levosimendan's Effects on Length-Dependent Activation in Murine Fast-Twitch Skeletal Muscle. [PDF]

Int J Mol Sci
Haug M, Michael M, Ritter P, Kovbasyuk L, Vazakidou ME, Friedrich O.   +5 more
europepmc   +1 more source

Effect of levosimendan on plasma intestinal barrier factors in heart failure patients with reduced ejection fraction. [PDF]

Zhong Nan Da Xue Xue Bao Yi Xue Ban
Wu Y, Hu X, Mao X, Liu H, Li S, Zeng Y, Xu P, Xiao H, Li D, Xia K.   +9 more
europepmc   +1 more source

The therapeutic effect of levosimendan in patients with prolonged ventilator weaning and cardiac dysfunction. [PDF]

J Int Med Res
Xiong F, Hu Z, Liu C, Zhang K, Zhou Q, Chen J, Lu H, Yue X, Zhao J, Pan P.   +9 more
europepmc   +1 more source

Efficacy and safety of levosimendan in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: The LEVOCEST trial. [PDF]

Catheter Cardiovasc Interv
Bosa Ojeda F, Méndez Vargas C, Lacalzada Almeida J, Izquierdo Gómez MM, Jiménez Sosa A, Rodríguez Jiménez C, Sánchez-Grande Flecha A, Bosa Santana M, Yanes Bowden G.   +8 more
europepmc   +1 more source

Levosimendan vs. Dobutamine in Patients with Septic Shock: A Systematic Review and Meta-Analysis with Trial Sequential Analysis. [PDF]

J Clin Med
Rodríguez EE, Jaramillo GAD, Cuellar LMR, Herran SEP, Lima DRR, Herpain A.   +5 more
europepmc   +1 more source

Impact of Levosimendan and Its Metabolites on Platelet Activation Mechanisms in Patients during Antiplatelet Therapy-Pilot Study. [PDF]

Int J Mol Sci
Sikora J, Pstrągowski K, Karczmarska-Wódzka A, Wszelaki P, Buszko K, Włodarczyk Z.   +5 more
europepmc   +1 more source

Levosimendan to Facilitate Weaning From ECMO in Patients With Severe Cardiogenic Shock: The LEVOECMO Randomized Clinical Trial.

JAMA
Combes A, Saura O, Nesseler N, Lebbah S, Rozec B, Levy B, Fellahi JL, Beurton A, Meslin S, Gaudard P, Bouglé A, Vincentelli A, Sonneville R, Lebreton G, Lévy D, Ouattara A, Tubach F, LEVOECMO Trial Group and the International ECMO Network (ECMONet).   +17 more
europepmc   +1 more source

Levosimendan mediates the BMP/Smad axis through upregulation of circUSP34-targeted miR-1298 to alleviate pulmonary hypertension. [PDF]

Respir Res
Meng Q, Song L, Wang H, Wang G, Zhou G.
europepmc   +1 more source

The association between levosimendan and mortality in patients with sepsis or septic shock: a systematic review and meta-analysis. [PDF]

Eur J Emerg Med
Ge Z, Gao Y, Lu X, Yu S, Qin M, Gong C, Walline JH, Zhu H, Li Y.   +8 more
europepmc   +1 more source

Potentiating Cerebral Perfusion Normalizes Glymphatic Dynamics in Systemic Inflammation. [PDF]

Adv Sci (Weinh)
Zhao R, Sun B, Wei P, Sun Y, He Q, Zhang K, Lu J, Zhu S, Yang Y, Guo Z.   +9 more
europepmc   +1 more source